Xi'an International Medical Investment Company Limited

SZSE:000516 Stock Report

Market Cap: CN¥12.3b

Xi'an International Medical Investment Future Growth

Future criteria checks 5/6

Xi'an International Medical Investment is forecast to grow earnings and revenue by 100.8% and 20.1% per annum respectively. EPS is expected to grow by 118.1% per annum. Return on equity is forecast to be 7.8% in 3 years.

Key information

100.8%

Earnings growth rate

118.1%

EPS growth rate

Healthcare earnings growth21.2%
Revenue growth rate20.1%
Future return on equity7.8%
Analyst coverage

Low

Last updated13 Sep 2024

Recent future growth updates

No updates

Recent updates

After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Oct 01
After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Jul 16
Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Jun 20
Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Mar 25
Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Feb 28
Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Earnings and Revenue Growth Forecasts

SZSE:000516 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20267,761381N/A1,2061
12/31/20257,077320N/A1,3512
12/31/20245,478100N/A6521
6/30/20244,829-3205041,203N/A
3/31/20244,732-3995101,084N/A
12/31/20234,618-3683251,087N/A
9/30/20234,141-5721161,153N/A
6/30/20233,853-803591,074N/A
3/31/20233,465-823-650891N/A
1/1/20232,711-1,177-727461N/A
9/30/20222,786-1,064-940294N/A
6/30/20222,683-1,058-1,269176N/A
3/31/20222,594-1,068-832184N/A
12/31/20212,921-822-1,203456N/A
9/30/20212,583-41-1,096374N/A
6/30/20212,27330-1,174379N/A
3/31/20211,96452-1,401252N/A
12/31/20201,60745-1,29741N/A
9/30/20201,391-882-2,168-285N/A
6/30/20201,188-753-2,627-422N/A
3/31/20201,046-622-3,378-313N/A
12/31/2019991-404-3,647-34N/A
9/30/2019896-68-3,460128N/A
6/30/2019872-19-3,775-554N/A
3/31/20191,1082,193-3,010-622N/A
12/31/20182,0392,184-2,471-772N/A
9/30/20182,9732,244-1,607-496N/A
6/30/20183,6172,280-995203N/A
3/31/20184,130152N/A424N/A
12/31/20174,060195N/A384N/A
9/30/20174,024190N/A335N/A
6/30/20173,984191N/A395N/A
3/31/20173,944214N/A415N/A
12/31/20163,931202N/A439N/A
9/30/20163,872260N/A362N/A
6/30/20163,866217N/A350N/A
3/31/20163,866197N/A260N/A
12/31/20153,900241N/A274N/A
9/30/20153,927328N/A262N/A
6/30/20153,960369N/A292N/A
3/31/20153,929382N/A318N/A
12/31/20143,883350N/A306N/A
9/30/20143,786213N/A399N/A
6/30/20143,645168N/A337N/A
3/31/20143,604142N/A241N/A
12/31/20133,566122N/A328N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000516 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).

Earnings vs Market: 000516 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 000516 is expected to become profitable in the next 3 years.

Revenue vs Market: 000516's revenue (20.1% per year) is forecast to grow faster than the CN market (13.2% per year).

High Growth Revenue: 000516's revenue (20.1% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 000516's Return on Equity is forecast to be low in 3 years time (7.8%).


Discover growth companies